REGENXBIO Inc. (RGNX)
5.93
-0.64 (-9.74%)
At close: Mar 03, 2025, 3:59 PM
5.92
-0.25%
After-hours: Mar 03, 2025, 04:00 PM EST
REGENXBIO Income Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 |
| Revenue | 90.24M | 112.72M | 470.35M | 154.57M | 35.23M | 218.5M | 10.39M | 4.59M | 7.59M | 6.12M | 6.09M |
| Cost of Revenue | 37.21M | 54.55M | 51.83M | 35.71M | 8.24M | 9.64M | 1.71M | 959K | 1.5M | 1.01M | 324K |
| Gross Profit | 53.03M | 58.18M | 418.51M | 118.85M | 26.99M | 208.87M | 8.68M | 3.63M | 6.08M | 5.11M | 5.76M |
| Operating Income | -268.13M | -262.88M | 159.98M | -119.23M | -149M | 88.1M | -75.89M | -65.34M | -23.14M | -3.68M | -4.78M |
| Interest Income | 25K | 342K | 719K | 4.27M | 2.95M | 8.95M | n/a | n/a | n/a | n/a | n/a |
| Pretax Income | -263.65M | -280.4M | 141.25M | -106.01M | -97.49M | 104.12M | -73.17M | -63.4M | -22.81M | -4M | -5.39M |
| Net Income | -263.49M | -280.32M | 127.84M | -111.25M | -94.73M | 99.94M | -73.17M | -62.97M | -22.81M | -4M | -5.39M |
| Selling & General & Admin | 88.49M | 85.28M | 79.33M | 63.82M | 51.81M | 36.85M | 27.23M | 23.59M | 11.91M | 3.85M | 5.47M |
| Research & Development | 232.27M | 242.45M | 181.44M | 166.29M | 124.19M | 83.87M | 57.22M | 45.48M | 17.28M | 4.96M | 5.05M |
| Other Expenses | 397K | -6.68M | -2.24M | 7.97M | -10K | 42K | 116K | -102K | -26K | -47K | n/a |
| Operating Expenses | 321.16M | 321.06M | 258.53M | 238.09M | 175.99M | 120.77M | 84.57M | 68.97M | 29.16M | 8.77M | 10.53M |
| Interest Expense | 6.86M | 23.25M | 26.28M | 771K | n/a | n/a | n/a | n/a | 20K | 321K | 611K |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 358.37M | 375.6M | 310.37M | 273.8M | 184.23M | 130.41M | 86.28M | 69.93M | 30.67M | 9.77M | 10.85M |
| Income Tax | -152K | -84K | 13.41M | 5.24M | -2.75M | 4.18M | 686K | -435K | -60K | 291K | 597K |
| Shares Outstanding (Basic) | 43.73M | 43.15M | 42.44M | 37.28M | 36.69M | 36.61M | 29.86M | 26.41M | 9.17M | 13.15M | 13.15M |
| Shares Outstanding (Diluted) | 43.73M | 43.15M | 43.91M | 37.28M | 36.69M | 36.65M | 29.88M | 26.41M | 9.17M | 13.15M | 13.15M |
| EPS (Basic) | -6.02 | -6.5 | 3.01 | -2.98 | -2.58 | 2.73 | -2.45 | -2.38 | -2.49 | -0.3 | -0.41 |
| EPS (Diluted) | -6.02 | -6.5 | 2.91 | -2.98 | -2.58 | 2.73 | -2.45 | -2.38 | -2.49 | -0.3 | -0.41 |
| EBITDA | -239.46M | -244.24M | 169.54M | -96.83M | -90.34M | 92.08M | -73.2M | -64.8M | -22.71M | -3.65M | -4.78M |
| Depreciation & Amortization | 17.32M | 12.91M | 9.56M | 8.41M | 7.15M | 3.98M | 2.69M | 544K | 80K | 30K | 14K |